Navigation Links
Salk researcher Terry Sejnowski elected to Institute of Medicine
Date:10/14/2008

Terry Sejnowski, Ph.D., professor and head of the Computational Neurobiology Laboratory at the Salk Institute has been elected to the Institute of Medicine, the IOM has announced. Election to the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

"It is a great pleasure to welcome these distinguished and influential individuals to the Institute of Medicine," said IOM President Harvey V. Fineberg. "Members are elected through a highly selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care, and public health."

A Howard Hughes Medical Institute investigator, Dr. Sejnowski's lab is interested in understanding how the brain represents the world with information stored in neurons that are distributed across the brain and how new representations are formed through learning algorithms, which are rules for changing the strengths of connections between neurons.

He has created computer models of networks of neurons to explore the mechanisms underlying attention in the awake brain and brain rhythms in the sleeping brain and the links between them. These models also help explain how epilepsy arises from imbalances in brain circuits.

Sejnowski's laboratory has developed new ways of analyzing the sources of electrical and magnetic signals recorded from the scalp and the signals picked up by functional magnetic resonance imaging (fMRI) of the brain that are used routinely by laboratories throughout the world to study normal and abnormal brain function.

Among other things, Dr. Sejnowski is interested in the hippocampus, believed to play a major role in learning and memory, and the cerebral cortex, which holds our knowledge of the world and how to interact with it. In his lab, Sejnowski's team uses sophisticated electrical and chemical monitoring techniques to measure changes that occur in the connections among nerve cells in the hippocampus during a simple form of learning. They use the results of these studies to instruct large-scale computers to mimic how these nerve cells work.

By studying how the resulting computer simulations can perform operations that resemble the activities of the hippocampus, Dr. Sejnowski hopes to gain new knowledge of how the human brain is capable of learning and storing memories. This knowledge ultimately may provide medical specialists with critical clues to combating Alzheimer's disease and other disorders that rob people of the critical ability to remember faces, names, places and events.

Sejnowski is also a fellow of the American Association for the Advancement of Science and has received many honors, including the Wright Prize for interdisciplinary research from Harvey Mudd College, the Hebb Prize and the Neural Network Pioneer Award from the Institute of Electrical and Electronics Engineers. He has published over 300 scientific papers and 12 books, including The Computational Brain, with UC San Diego professor of philosophy, Patricia Churchland.


'/>"/>

Contact: Mauricio Minotta
Minotta@salk.edu
858-453-410-01371
Salk Institute
Source:Eurekalert

Related biology news :

1. Researchers identify proteins involved in new neurodegenerative syndrome
2. Texas researchers and educators head for Antarctica
3. MGH researchers describe new way to identify, evolve novel enzymes
4. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
5. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
6. U of MN researchers discover noninvasive diagnostic tool for brain diseases
7. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
8. Researchers discover new strategies for antibiotic resistance
9. Researchers find new taste in fruit flies: carbonated water
10. Binghamton University researchers investigate evolving malaria resistance
11. Antioxidant to retard wrinkles discovered by Hebrew University researcher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017  IBM ... Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, Home ... that will apply the power of IBM cognitive computing ... health centers. By analyzing data streaming from sensors in ... physical and environmental conditions, and obtain deeper learnings into ...
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a community ... that it has received Laboratory Accreditation from the ... is presented to laboratories that meet stringent requirements ... scientifically rigorous processes. "Genos is committed ... laboratory practices. We,re honored to be receiving CAP ...
(Date:2/13/2017)...  RSA Conference -- RSA, a Dell Technologies business, ... enhance fraud detection and investigation across digital environments ... & Risk Intelligence Suite. The new platform is ... from internal and external sources as well as ... from targeted cybercrime attacks. "Fraudsters are ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... and ROCKVILLE, Md. , March ... of Maxwell Biotech Venture Fund (MBVF), today announced positive ... added to the standard drug therapy regimen in patients ... small molecule drug discovered by scientists at Sequella, Inc. ... Institutes of Health. A total of ...
(Date:3/24/2017)... , March 24, 2017   Sienna Biopharmaceuticals, Inc. ... company, today announced that Richard Peterson will ... 24.   Peterson, who brings more than two ... Smither , who is retiring at the end of ... advisory capacity. Peterson joins Sienna from Novan, Inc., where ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... ... The Global Market for Bioproducts Should Reach $714.6 Billion by ... 8.9%, This research report quantifies the two ... segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and herbal/botanicals), biocomposite materials, ...
(Date:3/23/2017)... -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical ... reported financial results for the quarter and year ... update on the company,s clinical development efforts and ... pleased to report that last year was a ... Krammer. "We achieved key clinical milestones and attracted ...
Breaking Biology Technology: